Direct-to-Consumer Genetic Testing: The Implications of the US FDA’s First Marketing Authorization for BRCA Mutation Testing

Overview of attention for article published in JAMA: Journal of the American Medical Association, June 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 317 X posts from 252 X users, with an upper bound of 2,633,712 followers.

@mssnytweet @NorthwellHealth

RT @MuinJKhoury: We still don’t know the balance of health benefits and harms of direct to consumer testing for BRCA mutations. Via @JAMA…

RT @MuinJKhoury: We still don’t know the balance of health benefits and harms of direct to consumer testing for BRCA mutations. Via @JAMA…

RT @MuinJKhoury: We still don’t know the balance of health benefits and harms of direct to consumer testing for BRCA mutations. Via @JAMA…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 313 additional X posts.